MATERIAL SAFETY DATA SHEET: Folligen Spray Water, sodium laureth sulfate, hydrolyzed soy protein, cocamidopropyl betain, NaC14-16 olefin sulfonate, PEG-3, phenoxyethanol, polyquaternium-7, cationic guar gum, butylene glycol, fragrance (lavender & chamomile), lauramide MEA, dl-panthenol, cupric chloride, leucine, vitamin E TPGS (tocophersolan), polysorbate 80, extracts of the following (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile), prunus serotina (wild cherry) and lawsonia inermis (henna) MATERIAL SAFETY DATA SHEET: Folligen Shampoo Folligen Therapy Conditioner: Water, hydrolyzed soy protein, squalane, olive oil, PEG100 stearate, behentrimonium methosulfate & cetearyl alcohol, cetyl alcohol, carthamus tinctorius seed (safflower) oil, phenoxyethanol, cetrimonium chloride, dl-panthenol, polyquaternium-7, glycerin, cationic guar gum, butylene glycol, serenoa serrulata fruit extract, polysorbate 20, fragrance (Aloe), allantoin, leucine, cupric chloride, vitamin E TPGS (tocophersolan), aloe barbadensis (aloe vera) powder, extracts of the following lawsonia inermis (henna), (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile) and prunus serotina (wild cherry) bark) *NOTE: Hydrolyzed soy protein used in this product is MATERIAL SAFETY DATA SHEET: Folligen Conditioner Emu Oil-S Lipid Replenisher for Hair: Emu oil (distilled and refined), serenoa serrulata fruit extract, ubiquinone (CoQ-10), vitamin E (as d-alpha tocopherol plus mixed tocopherols: d-beta, d-delta and d-gamma tocopherol), xanthophyll (Lutein)
Drug-Disease Interaction: Inform your doctor if you have a history of the following conditions before taking Fibrobos-XT Tablet 10's, as it may worsen your condition
Step 10 / Secure it against the head with more bobby pins
is co-inventor on two issued patents with royalties on radiomics (PCT/NL2014/050248 and PCT/NL2014/050728), licensed to Radiomics SA
It is much faster than the conventional method using gene targeting in ES cells, which involves many months of targeting vector construction, ES cells selection, and validation of targeted clones and achieving germline transmission from at least one clone
